{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:46:39Z","timestamp":1791481599570,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-COVID syndrome (PCS) is characterized by persistent heterogeneous symptoms after SARS-CoV-2 infection, yet objective biomarkers for symptom severity and longitudinal disease trajectories remain limited. We aimed to characterize muscle function over time in PCS and examine its relationship with symptom burden and neuroaxonal injury markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective observational study, patients fulfilling WHO criteria for PCS underwent standardized assessments at baseline (BL) and six-month follow-up (FU). Muscle function was assessed using a multidimensional handgrip strength (HGS) protocol capturing mean force (Fmean), fatigability (fatigue ratio), and recovery capacity alongside clinical symptom measures. Analyses included longitudinal assessment within the PCS cohort, comparisons with COVID-19 recovered controls, analysis of symptom persistence, and matched cohort analyses including HGS measures and circulating neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 204 participants (102 PCS, 102 recovered controls) PCS patients showed lower Fmean and higher fatigability at BL and FU (both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Muscle function parameters remained largely stable over six months, with only modest improvement in recovery (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015). HGS parameters correlated with symptom burden (\u03c1 \u2248 -0.28 to -0.33), and BL impairments were associated with worse fatigue and depressive symptoms at FU (e.g., Fmean\u2013PHQ-9: \u03b2 = -0.11,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022; fatigue ratio\u2013FSS: \u03b2\u2009=\u20091.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008). Exploratory analyses suggested slightly higher NfL and GFAP levels in PCS in some models, without consistent associations with muscle function or symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HGS is persistently reduced in PCS over at least six months and aligns with symptom burden. Multidimensional HGS assessment may provide a practical objective marker of functional impairment and symptom persistence in PCS. Neuroaxonal injury markers showed modest elevations in PCS in some analyses but appeared unrelated to muscle performance, suggesting partially distinct mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT05635552. Registered 1 December 2022 - Retrospectively registered, https:\/\/clinicaltrials.gov\/study\/NCT05635552?term=NCT05635552&amp;rank=1&amp;tab=study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08579-z","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:36:51Z","timestamp":1783438611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Persistent impairments in muscle function and symptom burden in post-COVID syndrome: a prospective longitudinal study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-5061","authenticated-orcid":false,"given":"Michael","family":"Wunderle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lethen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schmaderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timon","family":"Wallraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"4","key":"8579_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601\u201315.","journal-title":"Nat Med"},{"issue":"1","key":"8579_CR2","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/s41467-022-30836-0","volume":"13","author":"EJ Thompson","year":"2022","unstructured":"Thompson EJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528.","journal-title":"Nat Commun"},{"issue":"4","key":"8579_CR3","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"8579_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"8579_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41591-021-01361-2","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, et al. Author Correction: Attributes and predictors of long COVID. Nat Med. 2021;27(6):1116.","journal-title":"Nat Med"},{"key":"8579_CR6","doi-asserted-by":"crossref","unstructured":"Zu\u00f1iga-Jimenez CT, Rojas-Esguerra DF, Mu\u00f1oz-Martinez AP, Mendoza-Guzman DC, Daza-Arana JE. Musculoskeletal sequelae of post-COVID-19 syndrome: a systematic review. Diseases. 2025;13(12).","DOI":"10.3390\/diseases13120391"},{"issue":"5","key":"8579_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1071\/AH23271","volume":"48","author":"K Grove","year":"2024","unstructured":"Grove K, et al. Informing the management of the post-COVID condition: insights from the Western Australian experience comparing those who tested positive and negative to early COVID-19 strains. Aust Health Rev. 2024;48(5):601\u201311.","journal-title":"Aust Health Rev"},{"issue":"9","key":"8579_CR8","doi-asserted-by":"publisher","first-page":"e0332242","DOI":"10.1371\/journal.pone.0332242","volume":"20","author":"IDS Almeida","year":"2025","unstructured":"Almeida IDS, et al. Fatigue and neuromuscular function in long COVID: A one-year follow-up study. PLoS ONE. 2025;20(9):e0332242.","journal-title":"PLoS ONE"},{"key":"8579_CR9","doi-asserted-by":"publisher","first-page":"1641046","DOI":"10.3389\/fphys.2025.1641046","volume":"16","author":"LGJ Ferreira","year":"2025","unstructured":"Ferreira LGJ, et al. Long COVID-19 alters muscle architecture and muscle-tendon force transmission: a one-year longitudinal study. Front Physiol. 2025;16:1641046.","journal-title":"Front Physiol"},{"issue":"1","key":"8579_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41467-023-44432-3","volume":"15","author":"B Appelman","year":"2024","unstructured":"Appelman B, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15(1):17.","journal-title":"Nat Commun"},{"issue":"1","key":"8579_CR11","doi-asserted-by":"publisher","first-page":"p2049","DOI":"10.1038\/s41598-024-52401-z","volume":"14","author":"CMSS do Amaral","year":"2024","unstructured":"do Amaral CMSS, et al. Low handgrip strength is associated with worse functional outcomes in long COVID. Sci Rep. 2024;14(1):p2049.","journal-title":"Sci Rep"},{"key":"8579_CR12","doi-asserted-by":"crossref","unstructured":"Paffrath A, Kim L, Kedor C, Stein E, Rust R, Freitag H, et al. Impaired hand grip strength correlates with greater disability and symptom severity in post-COVID myalgic encephalomyelitis\/chronic fatigue syndrome. J Clin Med. 2024;13(7).","DOI":"10.3390\/jcm13072153"},{"key":"8579_CR13","doi-asserted-by":"crossref","unstructured":"Stoffels AAF, van Voorthuizen EL, van Hees HWH, Peters JB, van Helvoort HAC, Voermans NC, et al. Longitudinal analysis of quadriceps muscle strength in patients with previous COVID-19 hospitalization and in patients with post-acute sequelae following mild COVID-19. Nutrients. 2022;14(20).","DOI":"10.3390\/nu14204319"},{"issue":"1","key":"8579_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12967-021-02774-w","volume":"19","author":"B J\u00e4kel","year":"2021","unstructured":"J\u00e4kel B, et al. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME\/CFS. J Transl Med. 2021;19(1):159.","journal-title":"J Transl Med"},{"key":"8579_CR15","doi-asserted-by":"crossref","unstructured":"De Lorenzo R, Di Filippo L, Scelfo S, Merolla A, Giustina A, Conte C, et al. Longitudinal changes in physical function and their impact on health outcomes in COVID-19 patients. Nutrients. 2023;15(20).","DOI":"10.3390\/nu15204474"},{"issue":"10","key":"8579_CR16","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1097\/CCM.0000000000005089","volume":"49","author":"RJJ van Gassel","year":"2021","unstructured":"van Gassel RJJ, et al. Functional Outcomes and Their Association With Physical Performance in Mechanically Ventilated Coronavirus Disease 2019 Survivors at 3 Months Following Hospital Discharge: A Cohort Study. Crit Care Med. 2021;49(10):1726\u201338.","journal-title":"Crit Care Med"},{"issue":"8","key":"8579_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/covid5080140","volume":"5","author":"P Amput","year":"2025","unstructured":"Amput P, Udomkichpagon P, Wongphon S. Impact of Duration of Recovery from COVID-19 Infection on Physical Performance in Post-COVID-19 Patients. COVID. 2025;5(8):140.","journal-title":"COVID"},{"key":"8579_CR18","doi-asserted-by":"crossref","unstructured":"Ribeiro Neto F, Machado Marques J, Brasiliano da Paz M, Boiteux Uch\u00f4a Cavalcanti E, Gomes Costa RR. Sit-to-stand test and handgrip strength in men and women with post-COVID-19 syndrome without invasive ventilator support: insights from a Brazilian observational study. Monaldi Arch Chest Dis. 2024;94(3).","DOI":"10.4081\/monaldi.2023.2495"},{"key":"8579_CR19","doi-asserted-by":"crossref","unstructured":"Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4).","DOI":"10.1183\/13993003.03481-2020"},{"issue":"6","key":"8579_CR20","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1021\/acs.jproteome.1c00224","volume":"20","author":"E Holmes","year":"2021","unstructured":"Holmes E, et al. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome. J Proteome Res. 2021;20(6):3315\u201329.","journal-title":"J Proteome Res"},{"issue":"4","key":"8579_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4046\/trd.2024.0044","volume":"87","author":"T Ngamsutham","year":"2024","unstructured":"Ngamsutham T, et al. Pulmonary Function, Functional Capacity, Respiratory, and Locomotor Muscle Strength after Severe to Critically Ill COVID-19: A Long-Term Study. Tuberc Respir Dis (Seoul). 2024;87(4):532\u201342.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"8579_CR22","doi-asserted-by":"crossref","unstructured":"Middleton S, Chalitsios CV, Mungale T, Hassanein ZM, Jenkins AR, Bolton CE, et al. Functional recovery of adults following acute COVID-19: a systematic review and meta-analysis. Phys Ther. 2025;105(1).","DOI":"10.1093\/ptj\/pzae023"},{"issue":"5","key":"8579_CR23","first-page":"e20240246","volume":"50","author":"ERN Rebou\u00e7as","year":"2024","unstructured":"Rebou\u00e7as ERN, et al. Long COVID: a cross-sectional study of respiratory muscle strength, lung function, and persistent symptoms at one year after hospital discharge. J Bras Pneumol. 2024;50(5):e20240246.","journal-title":"J Bras Pneumol"},{"issue":"9","key":"8579_CR24","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1097\/j.pain.0000000000003259","volume":"165","author":"P Falco","year":"2024","unstructured":"Falco P, et al. Small fibre neuropathy frequently underlies the painful long-COVID syndrome. Pain. 2024;165(9):2002\u201310.","journal-title":"Pain"},{"issue":"2","key":"8579_CR25","doi-asserted-by":"publisher","first-page":"e70016","DOI":"10.1111\/ene.70016","volume":"32","author":"N Azcue","year":"2025","unstructured":"Azcue N, et al. Small fiber neuropathy in the post-COVID condition and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Clinical significance and diagnostic challenges. Eur J Neurol. 2025;32(2):e70016.","journal-title":"Eur J Neurol"},{"issue":"1","key":"8579_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41419-025-08162-2","volume":"17","author":"M Nunes","year":"2026","unstructured":"Nunes M, et al. Virus-induced endothelial senescence as a cause and driving factor for ME\/CFS and long COVID: mediated by a dysfunctional immune system. Cell Death Dis. 2026;17(1):16.","journal-title":"Cell Death Dis"},{"key":"8579_CR27","doi-asserted-by":"crossref","unstructured":"Zingaropoli MA, Perri V, Pasculli P, Cogliati Dezza F, Nijhawan P, Savelloni G, et al. Biomarkers of neurological damage: from acute stage to post-acute sequelae of COVID-19. Cells. 2023;12(18).","DOI":"10.3390\/cells12182270"},{"issue":"1","key":"8579_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-023-12090-6","volume":"271","author":"KZA Domingues","year":"2024","unstructured":"Domingues KZA, et al. Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19. J Neurol. 2024;271(1):1\u201323.","journal-title":"J Neurol"},{"key":"8579_CR29","doi-asserted-by":"publisher","first-page":"1750121","DOI":"10.3389\/fncel.2026.1750121","volume":"20","author":"M Wunderle","year":"2026","unstructured":"Wunderle M, et al. Serum NfL and GFAP in post-COVID syndrome: minimal evidence of CNS injury after adjusting for confounders. Front Cell Neurosci. 2026;20:1750121.","journal-title":"Front Cell Neurosci"},{"key":"8579_CR30","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.eclinm.2023.102146","volume":"63","author":"F Legler","year":"2023","unstructured":"Legler F, et al. Long-term symptom severity and clinical biomarkers in post-COVID-19\/chronic fatigue syndrome: results from a prospective observational cohort. EClinicalMedicine. 2023;63:102146.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"8579_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12967-022-03638-7","volume":"20","author":"F Retornaz","year":"2022","unstructured":"Retornaz F, et al. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis\/chronic fatigue syndrome: results of the retrospective CoLGEM study. J Transl Med. 2022;20(1):429.","journal-title":"J Transl Med"},{"key":"8579_CR32","doi-asserted-by":"crossref","unstructured":"Kuchler T, Hohberger B, Strunz S, Schieffer KM, Neuhann T, Schl\u00f6tzer-Schrehardt U, et al. All eyes on PCS: analysis of the retinal microvasculature in patients with post-COVID syndrome\u2014study protocol of a 1-year prospective case-control study. Eur Arch Psychiatry Clin Neurosci. 2023.","DOI":"10.1007\/s00406-023-01724-5"},{"issue":"4","key":"8579_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ageing\/afr051","volume":"40","author":"HC Roberts","year":"2011","unstructured":"Roberts HC, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423\u20139.","journal-title":"Age Ageing"},{"key":"8579_CR34","doi-asserted-by":"publisher","first-page":"101014","DOI":"10.1016\/j.jshs.2024.101014","volume":"14","author":"GR Tomkinson","year":"2025","unstructured":"Tomkinson GR, et al. International norms for adult handgrip strength: A systematic review of data on 2.4 million adults aged 20 to 100\u2009+\u2009years from 69 countries and regions. J Sport Health Sci. 2025;14:101014.","journal-title":"J Sport Health Sci"},{"issue":"3","key":"8579_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/jmv.27415","volume":"94","author":"RJ O\u2019Connor","year":"2022","unstructured":"O\u2019Connor RJ, et al. The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): Application and psychometric analysis in a post-COVID-19 syndrome cohort. J Med Virol. 2022;94(3):1027\u201334.","journal-title":"J Med Virol"},{"key":"8579_CR36","doi-asserted-by":"publisher","first-page":"101549","DOI":"10.1016\/j.eclinm.2022.101549","volume":"51","author":"T Bahmer","year":"2022","unstructured":"Bahmer T, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"8579_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","volume":"45","author":"LB Krupp","year":"1988","unstructured":"Krupp LB, et al. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435\u20137.","journal-title":"Arch Neurol"},{"key":"8579_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jad.2020.09.131","volume":"279","author":"L Costantini","year":"2021","unstructured":"Costantini L, et al. Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. J Affect Disord. 2021;279:473\u201383.","journal-title":"J Affect Disord"},{"issue":"3","key":"8579_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B L\u00f6we","year":"2008","unstructured":"L\u00f6we B, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266\u201374.","journal-title":"Med Care"},{"issue":"3","key":"8579_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"28","key":"8579_CR41","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"issue":"10","key":"8579_CR42","first-page":"e1164","volume":"6","author":"KP Mayer","year":"2024","unstructured":"Mayer KP, et al. Persistent Fatigue, Weakness, and Aberrant Muscle Mitochondria in Survivors of Critical COVID-19. Crit Care Explor. 2024;6(10):e1164.","journal-title":"Crit Care Explor"},{"issue":"3","key":"8579_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/BMR-220308","volume":"36","author":"JE de Azevedo Vieira","year":"2023","unstructured":"de Azevedo Vieira JE, et al. Assessment of short- and long-term functionality and quality of life in patients with post-acute COVID-19 syndrome. J Back Musculoskelet Rehabil. 2023;36(3):541\u201350.","journal-title":"J Back Musculoskelet Rehabil"},{"issue":"1","key":"8579_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chest.2021.08.010","volume":"161","author":"I Singh","year":"2022","unstructured":"Singh I, et al. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161(1):54\u201363.","journal-title":"Chest"},{"issue":"5","key":"8579_CR45","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000001348","volume":"152","author":"WK Cornwell","year":"2025","unstructured":"Cornwell WK, et al. Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV2 (Long COVID): A Scientific Statement From the American Heart Association. Circulation. 2025;152(5):e50\u201362.","journal-title":"Circulation"},{"issue":"1","key":"8579_CR46","doi-asserted-by":"publisher","first-page":"R154","DOI":"10.1152\/ajpregu.00055.2025","volume":"329","author":"BE Ono","year":"2025","unstructured":"Ono BE, et al. Sympathetic neural overdrive, vascular dysfunction, and diminished exercise capacity in patients with long COVID-19: a long-term study of cardiovascular sequelae. Am J Physiol Regul Integr Comp Physiol. 2025;329(1):R154\u201369.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"8579_CR47","doi-asserted-by":"publisher","first-page":"120380","DOI":"10.1016\/j.jns.2022.120380","volume":"441","author":"G Mak","year":"2022","unstructured":"Mak G, Menon S, Lu JQ. Neurofilaments in neurologic disorders and beyond. J Neurol Sci. 2022;441:120380.","journal-title":"J Neurol Sci"},{"key":"8579_CR48","doi-asserted-by":"publisher","first-page":"103512","DOI":"10.1016\/j.ebiom.2021.103512","volume":"70","author":"N Kanberg","year":"2021","unstructured":"Kanberg N, et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70:103512.","journal-title":"EBioMedicine"},{"issue":"4","key":"8579_CR49","doi-asserted-by":"publisher","first-page":"fcac195","DOI":"10.1093\/braincomms\/fcac195","volume":"4","author":"PJ Smeele","year":"2022","unstructured":"Smeele PJ, et al. Neurofilament light increases over time in severe COVID-19 and is associated with delirium. Brain Commun. 2022;4(4):fcac195.","journal-title":"Brain Commun"},{"key":"8579_CR50","doi-asserted-by":"publisher","first-page":"101472","DOI":"10.1016\/j.preteyeres.2026.101472","volume":"112","author":"T Wallraven","year":"2026","unstructured":"Wallraven T, et al. Retinal vessel imaging in inflammatory disease: From endothelial dysfunction to clinical evidence and translation. Prog Retin Eye Res. 2026;112:101472.","journal-title":"Prog Retin Eye Res"},{"key":"8579_CR51","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fneur.2018.00992","volume":"9","author":"LC Nacul","year":"2018","unstructured":"Nacul LC, et al. Hand Grip Strength as a Clinical Biomarker for ME\/CFS and Disease Severity. Front Neurol. 2018;9:992.","journal-title":"Front Neurol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08579-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:02:42Z","timestamp":1783519362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08579-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8579"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08579-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Technical University of Munich, School of Medicine (Klinikum rechts der Isar; approval number 2022-317-S-SR). The study was conducted in accordance with the Declaration of Helsinki and all participants provided written informed consent prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"871"}}